157 related articles for article (PubMed ID: 37321382)
1. TFEB is a central regulator of the aging process and age-related diseases.
Abokyi S; Ghartey-Kwansah G; Tse DY
Ageing Res Rev; 2023 Aug; 89():101985. PubMed ID: 37321382
[TBL] [Abstract][Full Text] [Related]
2. TFEB at a glance.
Napolitano G; Ballabio A
J Cell Sci; 2016 Jul; 129(13):2475-81. PubMed ID: 27252382
[TBL] [Abstract][Full Text] [Related]
3. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
[TBL] [Abstract][Full Text] [Related]
4. The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective.
Martini-Stoica H; Xu Y; Ballabio A; Zheng H
Trends Neurosci; 2016 Apr; 39(4):221-234. PubMed ID: 26968346
[TBL] [Abstract][Full Text] [Related]
5. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
6. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.
Cortes CJ; La Spada AR
Neurobiol Dis; 2019 Feb; 122():83-93. PubMed ID: 29852219
[TBL] [Abstract][Full Text] [Related]
7. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
8. The dual and emerging role of physical exercise-induced TFEB activation in the protection against Alzheimer's disease.
Morais GP; de Sousa Neto IV; Marafon BB; Ropelle ER; Cintra DE; Pauli JR; Silva ASRD
J Cell Physiol; 2023 May; 238(5):954-965. PubMed ID: 37013375
[TBL] [Abstract][Full Text] [Related]
9. TFEB Biology and Agonists at a Glance.
Chen M; Dai Y; Liu S; Fan Y; Ding Z; Li D
Cells; 2021 Feb; 10(2):. PubMed ID: 33562649
[TBL] [Abstract][Full Text] [Related]
10. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
[TBL] [Abstract][Full Text] [Related]
11. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease.
Tan A; Prasad R; Lee C; Jho EH
Cell Death Differ; 2022 Aug; 29(8):1433-1449. PubMed ID: 35739255
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 is required for CD38-mediated NAADP-Ca
Nabar NR; Heijjer CN; Shi CS; Hwang IY; Ganesan S; Karlsson MCI; Kehrl JH
Autophagy; 2022 Jan; 18(1):204-222. PubMed ID: 34313548
[TBL] [Abstract][Full Text] [Related]
13. The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB.
Zhang Z; Qian Q; Li M; Shao F; Ding WX; Lira VA; Chen SX; Sebag SC; Hotamisligil GS; Cao H; Yang L
Autophagy; 2021 Aug; 17(8):1841-1855. PubMed ID: 32597296
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies.
Akwa Y; Di Malta C; Zallo F; Gondard E; Lunati A; Diaz-de-Grenu LZ; Zampelli A; Boiret A; Santamaria S; Martinez-Preciado M; Cortese K; Kordower JH; Matute C; Lozano AM; Capetillo-Zarate E; Vaccari T; Settembre C; Baulieu EE; Tampellini D
Autophagy; 2023 Feb; 19(2):660-677. PubMed ID: 35867714
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the multifaced function of transcription factor EB (TFEB) in human diseases: From molecular mechanism to pharmacological modulation.
Zhang L; Li Z; Zhang L; Qin Y; Yu D
Biochem Pharmacol; 2023 Sep; 215():115698. PubMed ID: 37482200
[TBL] [Abstract][Full Text] [Related]
16. TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway.
Zhang YD; Zhao JJ
DNA Cell Biol; 2015 Nov; 34(11):661-8. PubMed ID: 26368054
[TBL] [Abstract][Full Text] [Related]
17. The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases.
Jiao F; Zhou B; Meng L
CNS Neurosci Ther; 2023 Jan; 29(1):37-59. PubMed ID: 36184826
[TBL] [Abstract][Full Text] [Related]
18. Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.
Meng X; Luo Y; Liang T; Wang M; Zhao J; Sun G; Sun X
J Alzheimers Dis; 2016 Apr; 52(3):1135-50. PubMed ID: 27060963
[TBL] [Abstract][Full Text] [Related]
19. A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity
Wang Z; Yang C; Liu J; Chun-Kit Tong B; Zhu Z; Malampati S; Gopalkrishnashetty Sreenivasmurthy S; Cheung KH; Iyaswamy A; Su C; Lu J; Song J; Li M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098449
[No Abstract] [Full Text] [Related]
20. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.
Zhang W; Wang J; Yang C
Autophagy; 2022 Jul; 18(7):1740-1742. PubMed ID: 35253615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]